InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

CVKD Stock Earnings: Cadrenal Therapeutics Misses EPS for Q2 2024

By InvestorPlace Earnings

CVKD stock results show that Cadrenal Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

SYRE Stock Earnings: Spyre Therapeutics Beats EPS for Q2 2024

By InvestorPlace Earnings

SYRE stock results show that Spyre Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

BNGO Stock Earnings: Bionano Genomics Beats EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings

BNGO stock results show that Bionano Genomics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

DRMA Stock Earnings: Dermata Therapeutics Misses EPS for Q2 2024

By InvestorPlace Earnings

DRMA stock results show that Dermata Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings

TBIO stock results show that Telesis Bio missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Load More